Physician profile
Maria Klimenko
NPI 1700453594
$4,995.32
in general payments reported to CMS, 2019-2025
21 companies · $830 in 2025
The $830 reported for 2025 was more than what 81% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $360 · 2022: $2,291 · 2023: $1,210 · 2024: $304 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $985.88 | 2022-2025 | |
| Galderma Laboratories, L.P. | $505.78 | 2022-2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $480.00 | 2023-2024 | Zoryve |
| Incyte Corporation | $410.13 | 2021-2025 | Opzelura |
| Journey Medical Corporation | $321.45 | 2022 | |
| Genzyme Corporation | $276.42 | 2021-2023 | |
| Ucb, INC. | $269.95 | 2022-2025 | Cimzia, Bimzelx |
| Medimetriks Pharmaceuticals, INC. | $250.00 | 2022 | |
| Sun Pharmaceutical Industries INC. | $244.57 | 2021-2023 | Ilumya |
| Pfizer INC. | $244.54 | 2021-2025 | |
| Lilly USA, LLC | $232.01 | 2022-2025 | Taltz, Ebglyss, Zepbound |
| E.R. Squibb & Sons, L.L.C. | $211.89 | 2022-2025 | Sotyktu |
| Janssen Biotech, INC. | $211.35 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $147.60 | 2021-2023 | Dupixent |
| Organon LLC | $41.17 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Strata Skin Sciences, INC. | $36.69 | 2025 | Xtrac |
| Leo Pharma INC. | $32.19 | 2025 | Anzupgo |
| Amgen INC. | $24.25 | 2023 | Otezla |
| Dermavant Sciences, INC. | $23.80 | 2023 | Vtama |
| Almirall LLC | $22.96 | 2025 | Seysara |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.69 | 2025 | Cabtreo, Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Klimenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.